Jiangsu Nhwa Pharmaceutical Co., Ltd.
SHZ: 002262.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jiaquan Sun
- Employees
- 5,923
- Headquarters
- Xuzhou, China
- IPO year
- 2008
- Market cap
- CN¥22.2B
- Website
- https://www.nhwa-group.com
Loading 002262…
Loading profile data…Frequently asked questions about 002262
What does Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) do?
Jiangsu Nhwa Pharmaceutical Co., LTD produces and sells central nervous system drugs, and cardiovascular and cerebrovascular drugs in China and internationally. The company offers drugs in the anesthesia, psychiatry, and neurological categories. It also provides APIs in the areas of central nervous system, anesthetic and sedative, and others. Th...
Where does 002262.SZ trade?
Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002262.SZ in?
Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jiangsu Nhwa Pharmaceutical Co., Ltd.?
Jiaquan Sun is the chief executive officer of Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ).
Where is Jiangsu Nhwa Pharmaceutical Co., Ltd. headquartered?
Jiangsu Nhwa Pharmaceutical Co., Ltd. is headquartered in China.
Does 002262.SZ pay a dividend?
Yes — Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) paid a trailing twelve-month dividend of CNY 0.36 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002262.SZ go public?
Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) completed its initial public offering in 2008.